Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Community-Acquired Bacterial Pneumonia (CABP)
.
Show all posts
Showing posts with label
Community-Acquired Bacterial Pneumonia (CABP)
.
Show all posts
Wednesday, January 22, 2020
FDA Approves Xenleta (lefamulin) to Treat Community-Acquired Bacterial Pneumonia (CABP)
›
Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative ...
›
Home
View web version
